Albert Farrugia

12 Followers

17 SlideShares 12 Followers 23 Followings

plasma fractionation therapeutics blood transfusion harmonisation technology thrombogenicity immunoglobulin blood safety patient blood management paradigms kuhn popper

Activity
About

Ruth Sanger Oration 2009

14 years ago • 851 Views

Biologicals Regulation in Australia

14 years ago • 449 Views

Interacting with Government

14 years ago • 382 Views

The precautionary principle

14 years ago • 977 Views

Safety and Supply of hemophilia products

14 years ago • 774 Views

Clinical trial options for rare diseases

14 years ago • 968 Views

Emerging infectious threats to the blood supply

14 years ago • 1694 Views

Science and Policy Making in Public Health

14 years ago • 353 Views

Plasma for fractionation and Patient Blood Management.

6 years ago • 351 Views

Humanitarian aid and access to haemophilia care

6 years ago • 391 Views

Affordability of haemophilia treatments

6 years ago • 158 Views

BRAZILIAN PROGRAM OF SELF-SUFFICIENCY IN BLOOD PRODUCTS

6 years ago • 98 Views

Blood safety issues 2018

6 years ago • 130 Views

Manufacture of Immunoglobulin Therapies-Relationship to Thrombogenicity

5 years ago • 98 Views

Plasma derived medicines - evidence and use

5 years ago • 70 Views

Disruptive technologies in the manufacture of plasma protein therapies

5 years ago • 366 Views

International challenges facing the Global Plasma Therapeutics industry

3 years ago • 64 Views

Presentation on EU GMP Annex 16 - Certification by QP

GMP EDUCATION : Not for Profit Organization • 8 years ago

Orphan Drugs

patrickconneran • 12 years ago

Intravenous immunoglobulin

Chulalongkorn Allergy and Clinical Immunology Research Group • 14 years ago